Posted by
Marketing OK’d for Device to Help Reduce IBS Symptoms in Adolescents

Marketing OK’d for Device to Help Reduce IBS Symptoms in Adolescents

Latest Healthy Kids News TUESDAY, June 11, 2019 (HealthDay News) — The IB-Stim has received marketing approval from the U.S. Food and Drug Administration as the first medical device used to help alleviate functional abdominal pain in 11- to 18-year-old patients with irritable bowel syndrome (IBS), the agency announced Friday. The prescription-only device is composed […]

Posted by
Zerbaxa Approved for Hospital-Acquired Bacterial Pneumonia

Zerbaxa Approved for Hospital-Acquired Bacterial Pneumonia

Latest Infectious Disease News TUESDAY, June 11, 2019 (HealthDay News) — Zerbaxa (ceftolozane and tazobactam) has been approved for a new indication to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years and older, the U.S. Food and Drug Administration announced yesterday. In 2014, the FDA first approved Zerbaxa for […]

Posted by
Surprising Ways Owning a Dog Is Good for Your Health

Surprising Ways Owning a Dog Is Good for Your Health

By Len CanterHealthDay Reporter Latest Exercise & Fitness News WEDNESDAY, June 12, 2019 (HealthDay News) — Apart from the sheer fun of owning a pet, having a dog enhances well-being and even personal growth in many ways. Caring for a dog teaches kids responsibility and offers everyone in the family unconditional love. Many studies have […]

Posted by
Xultophy (insulin degludec and liraglutide injection)

Xultophy (insulin degludec and liraglutide injection)

What are the side effects of Xultophy? WARNING Possible thyroid tumors, including cancer Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats and mice, liraglutide, one of the components of Xultophy 100/3.6, […]

Posted by
Chemoimmunotherapy Regimen Approved to Treat DLBCL

Chemoimmunotherapy Regimen Approved to Treat DLBCL

Latest Cancer News TUESDAY, June 11, 2019 (HealthDay News) — Polivy (polatuzumab vedotin-piiq), a novel antibody-drug conjugate, received approval to treat patients with diffuse large B-cell lymphoma (DLBCL) in combination with bendamustine and rituximab, the U.S. Food and Drug Administration announced today. The combination was approved for patients whose disease has progressed or returned after […]

Posted by
Cancer Survivors Predicted to Top 22 Million by 2030

Cancer Survivors Predicted to Top 22 Million by 2030

Latest Cancer News TUESDAY, June 11, 2019 (HealthDay News) — More Americans are surviving cancer, and their numbers could top 22 million in another decade, the American Cancer Society says. Currently, thanks to better screening and treatment, more than 17 million Americans who had cancer remain alive, the society said in a new report. While […]